Skip to main content

24.02.2025 | Themenschwerpunkt

Inhalation treatment of chronic obstructive pulmonary disease (COPD) in older patients

verfasst von: Carla Stenmanns, MD, Helmut Frohnhofen, Claudia Münks-Lederer, Sandhya Matthes

Erschienen in: Zeitschrift für Gerontologie und Geriatrie

Einloggen, um Zugang zu erhalten

Abstract

Chronic obstructive pulmonary disease (COPD) is frequent in older patients. Frailty, cognitive impairment and sarcopenia are predictors for inadequately performed lung function testing as well as presenting challenges in subsequent disease management. Underdiagnosis and suboptimal treatment are often the result of incomplete assessment of older COPD patients. Problems associated with older COPD patients are not adequately addressed in international guidelines, although numerous evidence-based strategies are available. A key aspect is the management of the various inhaler devices. Up to 60–80% of older patients with COPD do not use the inhalers correctly. Even when the inhaler technique is correct, there is undertreatment if the required inspiratory flow cannot be achieved. Given the high rate of suboptimal inhaler treatment in older patients with COPD, an analysis of the pitfalls is important. An objective measurement of inspiratory flow and assessment of cognition and coordination are essential. A possible clinical algorithm for the assessment of older patients with respect to inhaler treatment of COPD is presented in a consensus approach by the Pneumological Geriatric Medicine Working Group of the German Society of Pulmonologists.
Literatur
1.
Zurück zum Zitat Rabe KF, Watz H (2017) Chronic obstructive pulmonary disease. Lancet 389(10082):1931–1940CrossRefPubMed Rabe KF, Watz H (2017) Chronic obstructive pulmonary disease. Lancet 389(10082):1931–1940CrossRefPubMed
2.
Zurück zum Zitat Kotaki K, Ikeda H, Fukuda T, Yuhei K, Yuki F, Kawasaki M et al (2019) Trends in the prevalence of COPD in elderly individuals in an air-polluted city in Japan: a cross-sectional study. Int J Chron Obstruct Pulmon Dis 14:791–798CrossRefPubMedPubMedCentral Kotaki K, Ikeda H, Fukuda T, Yuhei K, Yuki F, Kawasaki M et al (2019) Trends in the prevalence of COPD in elderly individuals in an air-polluted city in Japan: a cross-sectional study. Int J Chron Obstruct Pulmon Dis 14:791–798CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Agustí A, Vogelmeier C, Faner R (2020) COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol 319(5):L879–Ll83CrossRefPubMed Agustí A, Vogelmeier C, Faner R (2020) COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol 319(5):L879–Ll83CrossRefPubMed
4.
Zurück zum Zitat Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G et al (2000) Quality control of spirometry in the elderly. The SA.R.A. study. SAlute respiration nell’Anziano = respiratory health in the elderly. Am J Respir Crit Care Med 161(4 Pt 1):1094–1100CrossRefPubMed Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G et al (2000) Quality control of spirometry in the elderly. The SA.R.A. study. SAlute respiration nell’Anziano = respiratory health in the elderly. Am J Respir Crit Care Med 161(4 Pt 1):1094–1100CrossRefPubMed
5.
Zurück zum Zitat Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG et al (2020) Reduction in all-cause mortality with fluticasone Furoate/Umeclidinium/Vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 201(12):1508–1516CrossRefPubMedPubMedCentral Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG et al (2020) Reduction in all-cause mortality with fluticasone Furoate/Umeclidinium/Vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 201(12):1508–1516CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F et al (2016) Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 71(5):689–695CrossRefPubMed Lahousse L, Ziere G, Verlinden VJ, Zillikens MC, Uitterlinden AG, Rivadeneira F et al (2016) Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 71(5):689–695CrossRefPubMed
7.
Zurück zum Zitat Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP (2019) Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc 16(2):217–224CrossRefPubMedPubMedCentral Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP (2019) Frailty and clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc 16(2):217–224CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C et al (2022) Functional status in older patients with cancer and a frailty risk profile: a multicenter observational study. J Geriatr Oncol 13(8):1162–1171CrossRefPubMed Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C et al (2022) Functional status in older patients with cancer and a frailty risk profile: a multicenter observational study. J Geriatr Oncol 13(8):1162–1171CrossRefPubMed
9.
Zurück zum Zitat Frohnhofen H, Schlitzer J, Stieglitz S (2022) Lung function test in advanced age. Z Gerontol Geriatr 55(7):603–612CrossRefPubMed Frohnhofen H, Schlitzer J, Stieglitz S (2022) Lung function test in advanced age. Z Gerontol Geriatr 55(7):603–612CrossRefPubMed
11.
Zurück zum Zitat Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. Cmaj 173(5):489–495CrossRefPubMedPubMedCentral Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. Cmaj 173(5):489–495CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A et al (2017) Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J 49(2) Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A et al (2017) Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J 49(2)
13.
Zurück zum Zitat Brusselle G, Himpe U, Fievez P, Leys M, Bogerd PS, Peché R et al (2023) Evolving to a single inhaler extrafine LABA/LAMA/ICS—Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE). Respir Med 218:107368CrossRefPubMed Brusselle G, Himpe U, Fievez P, Leys M, Bogerd PS, Peché R et al (2023) Evolving to a single inhaler extrafine LABA/LAMA/ICS—Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE). Respir Med 218:107368CrossRefPubMed
14.
Zurück zum Zitat Allen SC (1997) Competence thresholds for the use of inhalers in people with dementia. Age Ageing 26(2):83–86CrossRefPubMed Allen SC (1997) Competence thresholds for the use of inhalers in people with dementia. Age Ageing 26(2):83–86CrossRefPubMed
15.
Zurück zum Zitat Allen SC, Ragab S (2002) Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 78(915):37–39CrossRefPubMedPubMedCentral Allen SC, Ragab S (2002) Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 78(915):37–39CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Sanders MJ (2017) Guiding inspiratory flow: development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm Med 2017:1495867CrossRefPubMedPubMedCentral Sanders MJ (2017) Guiding inspiratory flow: development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm Med 2017:1495867CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hodkinson HM (1972) Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1(4):233–238CrossRefPubMed Hodkinson HM (1972) Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1(4):233–238CrossRefPubMed
18.
Zurück zum Zitat Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC (2002) Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 40(9):771–781CrossRefPubMed Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC (2002) Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 40(9):771–781CrossRefPubMed
19.
Zurück zum Zitat Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15(6):548–561CrossRefPubMed Shulman KI (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15(6):548–561CrossRefPubMed
20.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Frohnhofen H, Hagen O (2011) Handgrip strength measurement as a predictor for successful dry powder inhaler treatment: application in older individuals with COPD. Z Gerontol Geriatr 44(4):245–249CrossRefPubMed Frohnhofen H, Hagen O (2011) Handgrip strength measurement as a predictor for successful dry powder inhaler treatment: application in older individuals with COPD. Z Gerontol Geriatr 44(4):245–249CrossRefPubMed
22.
Zurück zum Zitat Sharma G, Mahler DA, Mayorga VM, Deering KL, Harshaw O, Ganapathy V (2017) Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chronic Obstr Pulm Dis 4(3):217–224PubMedPubMedCentral Sharma G, Mahler DA, Mayorga VM, Deering KL, Harshaw O, Ganapathy V (2017) Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation. Chronic Obstr Pulm Dis 4(3):217–224PubMedPubMedCentral
23.
Zurück zum Zitat Loh CH, Peters SP, Lovings TM, Ohar JA (2017) Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc 14(8):1305–1311CrossRefPubMed Loh CH, Peters SP, Lovings TM, Ohar JA (2017) Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc 14(8):1305–1311CrossRefPubMed
24.
Zurück zum Zitat Kawamatawong T, Khiawwan S, Pornsuriyasak P (2017) Peak inspiratory flow rate measurement by using in-check DIAL for the different inhaler devices in elderly with obstructive airway diseases. J Asthma Allergy 10:17–21CrossRefPubMedPubMedCentral Kawamatawong T, Khiawwan S, Pornsuriyasak P (2017) Peak inspiratory flow rate measurement by using in-check DIAL for the different inhaler devices in elderly with obstructive airway diseases. J Asthma Allergy 10:17–21CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Leving MT, Bosnic-Anticevich S, van Cooten J, de Sousa JC, Cvetkovski B, Dekhuijzen R et al (2022) Clinical recommendations for dry powder inhaler use in the management of COPD in primary care. NPJ Prim Care Respir Med 32(1):59CrossRefPubMedPubMedCentral Leving MT, Bosnic-Anticevich S, van Cooten J, de Sousa JC, Cvetkovski B, Dekhuijzen R et al (2022) Clinical recommendations for dry powder inhaler use in the management of COPD in primary care. NPJ Prim Care Respir Med 32(1):59CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Halpin DMG, Mahler DA (2022) A systematic review of published algorithms for selecting an inhaled delivery system in chronic obstructive pulmonary disease. Ann Am Thorac Soc 19(7):1213–1220CrossRefPubMed Halpin DMG, Mahler DA (2022) A systematic review of published algorithms for selecting an inhaled delivery system in chronic obstructive pulmonary disease. Ann Am Thorac Soc 19(7):1213–1220CrossRefPubMed
27.
Zurück zum Zitat Bao LK, Khoa ND, Chi LTK, Anh NT (2023) Prevalence and factors affecting appropriate inhaler use in elderly patients with chronic obstructive pulmonary disease: a prospective study. J Clin Med 12(13) Bao LK, Khoa ND, Chi LTK, Anh NT (2023) Prevalence and factors affecting appropriate inhaler use in elderly patients with chronic obstructive pulmonary disease: a prospective study. J Clin Med 12(13)
28.
Zurück zum Zitat Huber B, Keller C, Jenkins M, Raza A, Aurivillius M (2022) Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow. Ther Adv Respir Dis 16:17534666221107312CrossRefPubMedPubMedCentral Huber B, Keller C, Jenkins M, Raza A, Aurivillius M (2022) Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow. Ther Adv Respir Dis 16:17534666221107312CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Gemicioglu B (2019) Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients. Eur Respir J 54(63) Gemicioglu B (2019) Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients. Eur Respir J 54(63)
30.
Zurück zum Zitat Dalby R, Spallek M, Voshaar T (2004) A review of the development of respimat soft mist inhaler. Int J Pharm 283(1–2):1–9CrossRefPubMed Dalby R, Spallek M, Voshaar T (2004) A review of the development of respimat soft mist inhaler. Int J Pharm 283(1–2):1–9CrossRefPubMed
31.
Zurück zum Zitat Komalla V, Wong CYJ, Sibum I, Muellinger B, Nijdam W, Chaugule V et al (2023) Advances in soft mist inhalers. Expert Opin Drug Deliv 20(8):1055–1070CrossRefPubMed Komalla V, Wong CYJ, Sibum I, Muellinger B, Nijdam W, Chaugule V et al (2023) Advances in soft mist inhalers. Expert Opin Drug Deliv 20(8):1055–1070CrossRefPubMed
32.
Zurück zum Zitat Iwanaga T, Tohda Y, Nakamura S, Suga Y (2019) The respimat(®) soft mist inhaler: implications of drug delivery characteristics for patients. Clin Drug Investig 39(11):1021–1030CrossRefPubMedPubMedCentral Iwanaga T, Tohda Y, Nakamura S, Suga Y (2019) The respimat(®) soft mist inhaler: implications of drug delivery characteristics for patients. Clin Drug Investig 39(11):1021–1030CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Ferguson GT, Goodin T, Tosiello R, Wheeler A, Kerwin E (2017) Long-term safety of glycopyrrolate/eflow(®) CS in moderate-to-very-severe COPD: results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 5 randomized study. Respir Med 132:251–260CrossRefPubMed Ferguson GT, Goodin T, Tosiello R, Wheeler A, Kerwin E (2017) Long-term safety of glycopyrrolate/eflow(®) CS in moderate-to-very-severe COPD: results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 5 randomized study. Respir Med 132:251–260CrossRefPubMed
34.
Zurück zum Zitat Nikander K, Agertoft L, Pedersen S (2000) Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J Asthma 37(5):451–459CrossRefPubMed Nikander K, Agertoft L, Pedersen S (2000) Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J Asthma 37(5):451–459CrossRefPubMed
35.
Zurück zum Zitat Gupta S, Couillard S, Digby G, Tse SM, Green S, Penz E (2024) Climate change and inhaler selection in patients with respiratory disease. Chest 165(3):503–506CrossRefPubMed Gupta S, Couillard S, Digby G, Tse SM, Green S, Penz E (2024) Climate change and inhaler selection in patients with respiratory disease. Chest 165(3):503–506CrossRefPubMed
36.
Zurück zum Zitat Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E et al (2018) Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res 19(1):10CrossRefPubMedPubMedCentral Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E et al (2018) Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res 19(1):10CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Barbara S, Kritikos V, Bosnic-Anticevich S (2017) Inhaler technique: does age matter? a systematic review. Eur Respir Rev 26(146) Barbara S, Kritikos V, Bosnic-Anticevich S (2017) Inhaler technique: does age matter? a systematic review. Eur Respir Rev 26(146)
38.
Zurück zum Zitat Maricoto T, Monteiro L, Gama JMR, Correia-de-Sousa J, Taborda-Barata L (2019) Inhaler technique education and exacerbation risk in older adults with asthma or chronic obstructive pulmonary disease: a meta-analysis. J Am Geriatr Soc 67(1):57–66CrossRefPubMed Maricoto T, Monteiro L, Gama JMR, Correia-de-Sousa J, Taborda-Barata L (2019) Inhaler technique education and exacerbation risk in older adults with asthma or chronic obstructive pulmonary disease: a meta-analysis. J Am Geriatr Soc 67(1):57–66CrossRefPubMed
39.
Zurück zum Zitat Vogelmeier C, Buhl R, Burghuber O, Criée CP, Ewig S, Godnic-Cvar J et al (2018) Guideline for the diagnosis and treatment of COPD patients—issued by the German respiratory society and the German atemwegsliga in cooperation with the austrian society of pneumology. Pneumologie 72(4):253–308PubMed Vogelmeier C, Buhl R, Burghuber O, Criée CP, Ewig S, Godnic-Cvar J et al (2018) Guideline for the diagnosis and treatment of COPD patients—issued by the German respiratory society and the German atemwegsliga in cooperation with the austrian society of pneumology. Pneumologie 72(4):253–308PubMed
40.
Zurück zum Zitat Meena M, Arora P, Goud MS, Kumar L (2023) To study the effectiveness of inhalation technique training in patients with COPD and asthma. J Assoc Physicians India 71(5):11–12PubMed Meena M, Arora P, Goud MS, Kumar L (2023) To study the effectiveness of inhalation technique training in patients with COPD and asthma. J Assoc Physicians India 71(5):11–12PubMed
41.
Zurück zum Zitat Wang W, Xu T, Qin Q, Miao L, Bao J, Chen R (2020) Effect of a multidimensional pharmaceutical care intervention on inhalation technique in patients with asthma and COPD. Can Respir J 2020:8572636CrossRefPubMedPubMedCentral Wang W, Xu T, Qin Q, Miao L, Bao J, Chen R (2020) Effect of a multidimensional pharmaceutical care intervention on inhalation technique in patients with asthma and COPD. Can Respir J 2020:8572636CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Garin N, Zarate-Tamames B, Gras-Martin L, Milà R, Crespo-Lessmann A, Curto E et al (2023) Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis. Pharmaceuticals 16(3) Garin N, Zarate-Tamames B, Gras-Martin L, Milà R, Crespo-Lessmann A, Curto E et al (2023) Clinical impact of electronic monitoring devices of inhalers in adults with asthma or COPD: a systematic review and meta-analysis. Pharmaceuticals 16(3)
43.
Zurück zum Zitat Knipel V, Schwarz S, Magnet FS, Storre JH, Criée CP, Windisch W (2017) Checklists for the assessment of correct inhalation therapy. Pneumologie 71(2):96–105CrossRefPubMed Knipel V, Schwarz S, Magnet FS, Storre JH, Criée CP, Windisch W (2017) Checklists for the assessment of correct inhalation therapy. Pneumologie 71(2):96–105CrossRefPubMed
Metadaten
Titel
Inhalation treatment of chronic obstructive pulmonary disease (COPD) in older patients
verfasst von
Carla Stenmanns, MD
Helmut Frohnhofen
Claudia Münks-Lederer
Sandhya Matthes
Publikationsdatum
24.02.2025
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-025-02411-x